Pósán E - Search Results

1

[Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera].

Pósán E, Ujj G, Kiss A, Telek B, Rák K, Udvardy M. Pósán E, et al. Orv Hetil. 1996 Jan 14;137(2):71-4. Orv Hetil. 1996. PMID: 8721871 Hungarian.

2

Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.

Pósán E, Ujj G, Kiss A, Telek B, Rák K, Udvardy M. Pósán E, et al. Thromb Res. 1998 Apr 15;90(2):51-6. doi: 10.1016/s0049-3848(98)00005-x. Thromb Res. 1998. PMID: 9684757

3

[Hemostasis in liver diseases].

Udvardy M, Pósán E, Tornai I. Udvardy M, et al. Among authors: posan e. Orv Hetil. 2000 May 7;141(19):1003-8. Orv Hetil. 2000. PMID: 10846421 Review. Hungarian.

4

[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].

Pósán E, Tornai I, Udvardy M. Pósán E, et al. Orv Hetil. 1994 Dec 18;135(51):2821-4. Orv Hetil. 1994. PMID: 7838517 Hungarian.

5

[Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].

Udvardy M, Pósán E. Udvardy M, et al. Among authors: posan e. Orv Hetil. 1994 Sep 11;135(37):2025-7. Orv Hetil. 1994. PMID: 7936609 Hungarian.

6

[Correlation between thrombocytes and fibrinolysis].

Udvardy M, Pósán E, Rák K. Udvardy M, et al. Among authors: posan e. Orv Hetil. 1994 Mar 27;135(13):677-80. Orv Hetil. 1994. PMID: 8170667 Hungarian.

7

[Correlation between adhesive factors of primary hemostasis and liver fibrogenesis in alcoholic live cirrhosis].

Udvardy M, Hársfalvi J, Pósán E, Káplár M, Katona E, Rák K. Udvardy M, et al. Among authors: posan e. Orv Hetil. 1994 Mar 6;135(10):523-6. Orv Hetil. 1994. PMID: 8146008 Clinical Trial. Hungarian.

8

Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus.

Udvardy M, Posan E, Harsfalvi J. Udvardy M, et al. Among authors: posan e. Thromb Res. 1995 Jul 1;79(1):57-63. doi: 10.1016/0049-3848(95)00090-e. Thromb Res. 1995. PMID: 7495104

9

New pentamidine related substances which simultaneously inhibit platelet aggregation and accelerate plasmin generation and in vitro clot lysis.

Udvardy M, Posan E, Harsfalvi J, Dinya Z. Udvardy M, et al. Among authors: posan e. Blood Coagul Fibrinolysis. 1996 Mar;7(2):256-8. doi: 10.1097/00001721-199603000-00037. Blood Coagul Fibrinolysis. 1996. PMID: 8735833

10

RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets.

Udvardy M, Schwartzott D, Jackson K, Posan E, Rak K, McKee PA. Udvardy M, et al. Among authors: posan e. Blood Coagul Fibrinolysis. 1995 Jul;6(5):481-5. Blood Coagul Fibrinolysis. 1995. PMID: 8589217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters